Status:
COMPLETED
Neuroelectrical Biomarkers for Alzheimer's Disease Stages
Lead Sponsor:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Alzheimer Disease
Eligibility:
All Genders
70-85 years
Phase:
NA
Brief Summary
Recent diagnostic criteria for Alzheimer's disease (AD) recognize an extended spectrum of AD stages as part of the disease, including a preclinical stage. This underscores the importance of early prog...
Eligibility Criteria
Inclusion
- Age: 70-85 years old
- Presence of memory impairment
- Completed educational level: middle school
- Visual and auditory acuity: normal or corrected-to-normal
Exclusion
- Monogenic AD
- Presence of a neurological disorder
- Stroke that has occurred in the last three months
- Prohibited medications
- Residence in skilled nursing facility
- Illiteracy, is unable to count or to read
- Claustrophobia
Key Trial Info
Start Date :
July 12 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2019
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT01880151
Start Date
July 12 2013
End Date
January 1 2019
Last Update
August 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Memory and Alzheimer's Disease, Pitie-Salpetriere Hospital
Paris, France, 75013